The summary decision came more than two years after shareholders of the acquired company FerroKin Biosciences Inc. proved they were entitled to a missed clinical trial milestone payment.
November 18, 2021 at 06:09 PM
3 minute read
The original version of this story was published on Delaware Business Court Insider
The Delaware Supreme Court on Wednesday upheld a judgment of more than $80 million against Shire U.S. Holdings Inc. in the case that’s uniquely both gone to trial and been appealed on contingency.
The summary decision came more than two years after shareholders of the acquired company FerroKin Biosciences Inc. proved they were entitled to a missed clinical trial milestone payment.
Deal Watch: Skadden, Sidley, Slaughter and S&C Lead Big Paper Deal, While Private Funds Grow Massive
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Delaware Supreme Court chamber in Dover, Delaware. Credit: Nagel Photography/Shutterstock.com
